Switching to aflibercept versus continuing bevacizumab for treatment‐resistant neovascular age‐related macular degeneration: a one‐year comparative observational study-Reference-Cited by-同舟云学术

Switching to aflibercept versus continuing bevacizumab for treatment‐resistant neovascular age‐related macular degeneration: a one‐year comparative observational study

Published:2021-02-26 Issue:8 Volume:99 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Husum Yngvil Solheim¹^ORCID,Moe Morten Carstens¹²,Bragadóttir Ragnheiður¹²,Jørstad Øystein Kalsnes¹²^ORCID

Affiliation:

1. Department of Ophthalmology Oslo University Hospital Oslo Norway

2. Institute for Clinical Medicine Faculty of Medicine University of Oslo Oslo Norway

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14825

Reference21 articles.

1. ASRS Global Trends in Retina2019.https://www.asrs.org/sections/international/global‐trends‐in‐retina(accessed 2020.09.28)

2. Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol

3. Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

4. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

5. Natural history and prognosis of choroidal neovascularization

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration;Ophthalmology Retina;2024-08

2. Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept;Journal of the Korean Ophthalmological Society;2022-06-15

3. Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression;Journal of Clinical Medicine;2022-01-10

4. Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options;Cells;2021-04-29